Image

Global Clot Management Devices Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Medical Devices
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Clot Management Devices Market, By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior vena cava filters (IVCF), Percutaneous Thrombectomy Devices), End Use (Hospitals, Diagnostic Centers, Others) – Industry Trends and Forecast to 2029

Clot Management Devices Market

Clot Management Devices Market Analysis and Size

The global market for clot management devices is experiencing growth to the rising demand for less invasive procedures and the enormous untapped market for clot management devices in emerging nations. The demand for inexpensive and effective clot control devices is being fuelled by cutting-edge research and development centres and new product introductions by the key companies.

Data Bridge Market Research analyses that the clot management devices market which was USD 1.6 billion in 2021, would rocket up to USD 2.37 billion by 2029, and is expected to undergo a CAGR of 5.05% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior vena cava filters (IVCF), Percutaneous Thrombectomy Devices), End Use (Hospitals, Diagnostic Centers, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Angio Dynamics, Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), EKOS Corporation (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Medtronic (Ireland), Stryker (U.S.) and Volcano Corporation (U.S.)

Market Opportunities

  • Increase number of patients with clots in cardiovascular and peripherals vascular systems
  • Rapid technological advancements
  • Development of novel next-generation thrombectomy tools

Market Definition

The process of haemostasis ends with the formation of a blood clot. The term "thrombus" also refers to clots. The two components of a blood clot are clumped platelets and red blood cells, which together form a plug and a mesh of cross-linked fibrin protein. A clot blocks blood flow to the heart, brain, lungs, and legs. When a blood clot forms in the body, it can lead to severe problems such blood vessel damage, hypertension, stroke, and occasionally even death. Another significant factor in cancer patients' deaths is blood clot. Surgery and anti-coagulation medications are both options for treating blood clots.

Global Clot Management Devices Market Dynamics

Drivers

  • Technological improvements

The market entry of clot management devices will be supported by the development of revolutionary next-generation thrombectomy tools and the rapid improvement of technology. The market share for clot supervision will also grow as a result of prompt administrative clearances for self-monitoring technologies. The rising older population, which is more susceptible to acquiring such infections, is a factor in the expansion.

  • Increasing demand of hospitals

Over the forecast period, it is anticipated that there will be potential due to the growing demand to reduce hospital investments and waiting times for low-risk lump extraction techniques.

  • Increasing demand for minimally invasive procedures

According to the World Health Organization (WHO), cardiovascular diseases cause 17.9 million deaths every year worldwide. Moreover, growing prevalence of stroke and heart attack, are the major driving factor for growing demand of minimally invasive procedures in the treatment of blood clots is expected to boost the market growth.

Opportunities

  • Rising demand of thrombectomy devices

In the upcoming years, the market will be expanded due to rising thrombectomy/embolectomy device demand and increased knowledge of novel clot management techniques. Another important factor is the increasing understanding of the advantages of percutaneous thrombectomy devices over the conventional method of removing clots through open surgery among patients and healthcare professionals.

Restraints/Challenges

On the other hand, the lack of compensation plans and knowledge of preventative medical exams to detect blood clotting will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the clot management devices market.

This clot management devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clot management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In January 2019, A Registry to Study Stroke-Inducing Blood Clots that Removed by Thrombectomy was created by Johnson & Johnson Medical Devices in January 2019. This initiative is helpful because it offers a wide range of devices suited for endovascular treatment of hemorrhagic and ischemic stroke.

Global Clot Management Devices Market Scope

The clot management devices market is segmented on the basis of product and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Percutaneous Thrombectomy Devices
  • Mechanical Thrombectomy
  • Aspiration Thrombectomy
  • Percutaneous Mechanical Thrombectomy (PMT)
  • Embolectomy Balloon Catheters
  • Catheter-Directed Thrombolysis (CDT) Devices
  • Inferior Vena Cava Filters (IVCFS)
  • Permanent
  • Retrievable
  • Neurovascular Embolectomy Devices

End User

  • Hospitals
  • Diagnostic Centers
  • Others

Clot Management Devices Market Regional Analysis/Insights

The clot management devices market is analysed and market size insights and trends are provided by country, product and end use as referenced above.

The countries covered in the clot management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the clot management devices market due to the increasing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the shift in living patterns and an expansion in disposable earnings, growing prevalence of target diseases coupled with improvement in healthcare infrastructure and introduction of technologically advanced products.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The clot management devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for clot management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the clot management devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Clot Management Devices Market Share Analysis

The clot management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to clot management devices market.

Some of the major players operating in the clot management devices market are:

  • Angio Dynamics, Inc. (U.S.)
  • Applied Medical Resources Corporation (U.S.)
  • Bayer AG (Germany)
  • Boston Scientific Corporation (U.S.)
  • Edwards Lifesciences Corporation (U.S.)
  • EKOS Corporation (U.S.)
  • Janssen Pharmaceuticals, Inc. (U.S.)
  • Medtronic (Ireland)
  • Stryker (U.S.)
  • Volcano Corporation (U.S.)


SKU-

Why Choose Us


Frequently Asked Questions

The clot management devices market value is expected USD 2.37 billion by 2029.
The key opportunities of the market are ncrease number of patients with clots in cardiovascular and peripherals vascular systems, Rapid technological advancements ,& Development of novel next-generation thrombectomy tools.
The market is to grow at a CAGR of 5.05% during the forecast by 2029.
The major players operating in the market are Angio Dynamics, Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), EKOS Corporation (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Medtronic (Ireland), Stryker (U.S.) and Volcano Corporation (U.S.).